These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8901556)

  • 1. The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor.
    Xu J; Nawaz Z; Tsai SY; Tsai MJ; O'Malley BW
    Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12195-9. PubMed ID: 8901556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor.
    Vegeto E; Allan GF; Schrader WT; Tsai MJ; McDonnell DP; O'Malley BW
    Cell; 1992 May; 69(4):703-13. PubMed ID: 1586949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor.
    Meyer ME; Pornon A; Ji JW; Bocquel MT; Chambon P; Gronemeyer H
    EMBO J; 1990 Dec; 9(12):3923-32. PubMed ID: 2249658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
    Leonhardt SA; Altmann M; Edwards DP
    Mol Endocrinol; 1998 Dec; 12(12):1914-30. PubMed ID: 9849965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
    Jackson TA; Richer JK; Bain DL; Takimoto GS; Tung L; Horwitz KB
    Mol Endocrinol; 1997 Jun; 11(6):693-705. PubMed ID: 9171233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor.
    Giangrande PH; Pollio G; McDonnell DP
    J Biol Chem; 1997 Dec; 272(52):32889-900. PubMed ID: 9407067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400.
    Wardell SE; Narayanan R; Weigel NL; Edwards DP
    Mol Endocrinol; 2010 Feb; 24(2):335-45. PubMed ID: 20008003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor.
    Zhang X; Jeyakumar M; Petukhov S; Bagchi MK
    Mol Endocrinol; 1998 Apr; 12(4):513-24. PubMed ID: 9544987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.
    Giangrande PH; Kimbrel EA; Edwards DP; McDonnell DP
    Mol Cell Biol; 2000 May; 20(9):3102-15. PubMed ID: 10757795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The leucine zippers of c-fos and c-jun for progesterone receptor dimerization: A-dominance in the A/B heterodimer.
    Mohamed MK; Tung L; Takimoto GS; Horwitz KB
    J Steroid Biochem Mol Biol; 1994 Dec; 51(5-6):241-50. PubMed ID: 7826885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP.
    Sartorius CA; Tung L; Takimoto GS; Horwitz KB
    J Biol Chem; 1993 May; 268(13):9262-6. PubMed ID: 8387487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo.
    Tetel MJ; Giangrande PH; Leonhardt SA; McDonnell DP; Edwards DP
    Mol Endocrinol; 1999 Jun; 13(6):910-24. PubMed ID: 10379890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486.
    Liu Z; Auboeuf D; Wong J; Chen JD; Tsai SY; Tsai MJ; O'Malley BW
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):7940-4. PubMed ID: 12048256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors.
    Tung L; Mohamed MK; Hoeffler JP; Takimoto GS; Horwitz KB
    Mol Endocrinol; 1993 Oct; 7(10):1256-65. PubMed ID: 8123133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells.
    Wen DX; Xu YF; Mais DE; Goldman ME; McDonnell DP
    Mol Cell Biol; 1994 Dec; 14(12):8356-64. PubMed ID: 7969170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
    Gass EK; Leonhardt SA; Nordeen SK; Edwards DP
    Endocrinology; 1998 Apr; 139(4):1905-19. PubMed ID: 9528977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways.
    Beck CA; Weigel NL; Moyer ML; Nordeen SK; Edwards DP
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4441-5. PubMed ID: 8389450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional activity.
    McDonnell DP; Shahbaz MM; Vegeto E; Goldman ME
    J Steroid Biochem Mol Biol; 1994 Apr; 48(5-6):425-32. PubMed ID: 8180103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type II antagonists impair the DNA binding of steroid hormone receptors without affecting dimerization.
    Bocquel MT; Ji J; Ylikomi T; Benhamou B; Vergezac A; Chambon P; Gronemeyer H
    J Steroid Biochem Mol Biol; 1993 Apr; 45(4):205-15. PubMed ID: 8499329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation.
    Allan GF; Leng X; Tsai SY; Weigel NL; Edwards DP; Tsai MJ; O'Malley BW
    J Biol Chem; 1992 Sep; 267(27):19513-20. PubMed ID: 1326555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.